FindTrial
Sign In

Integrating clinical-pathological-MRI features to construct a prediction model for pathological complete remission of axillary lymph nodes after neoadjuvant therapy

Integrating clinical-pathological-MRI features to construct a prediction model for pathological complete remission of axillary lymph nodes after neoadjuvant therapy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500101342
Enrollment
Unknown
Registered
2025-04-23
Start date
2025-04-05
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

apCR group:None
non-apCR group:None

Sponsors

Radiology Department, The Affiliated Hospital of Southwest Medical University, Luzhou, China
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Female patients; (2) all breast cancer patients diagnosed by histopathological pathology; (3) all received neoadjuvant therapy; (4) Metastases were confirmed by lymph node biopsy before neoadjuvant therapy; (5) Complete clinical, pathological and magnetic resonance data; (6) After neoadjuvant therapy, all completed surgery and underwent axillary lymph node dissection.

Exclusion criteria

Exclusion criteria: (1) Male patients; (2) Failure to complete neoadjuvant therapy or failure to carry out standardized neoadjuvant therapy; (3) the patient's profile is incomplete; (4) The patient underwent NAT in another hospital; (5) Magnetic resonance characteristics cannot be measured.

Design outcomes

Primary

MeasureTime frame
Initial diagnosis age;—

Countries

China

Contacts

Public ContactYi Quan

The Affiliated Hospital of Southwest Medical University, Luzhou, China

20783833@qq.com+86 135 6815 0605

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026